NSAID Prostate Cancer Benefits Greatest In Older Men – Mayo Clinic Study
This article was originally published in The Tan Sheet
Executive Summary
Daily nonsteroidal anti-inflammatory drug (NSAID) use resulted in an 83% reduced risk of prostate cancer in white men ages 70 to 79, a study in the March Mayo Clinic Proceedings found